Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 12th April 2023
In the ordinary rebalance, the following index composition will be implemented effective open 12.04.2023:
ABBOTT LABORATORIES |
ABBVIE INC |
ALCON INC |
AMGEN INC |
BAYER AG |
BECTON DICKINSON AND CO |
BIOGEN INC |
BIOMERIEUX |
BRISTOL-MYERS SQUIBB CO |
CENTENE |
COLOPLAST AS CLASS B |
ELEVANCE HEALTH INC |
ELI LILLY & CO |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
ESSILORLUXOTTICA |
FRESENIUS SE & CO KGAA |
GENMAB A/S |
GILEAD SCIENCES INC |
GSK PLC |
HOLOGIC INC |
HUMANA INC |
INCYTE CORP |
JAZZ PHARMACEUTICALS PLC |
JOHNSON & JOHNSON |
LABORATORY CRP OF AMER HLDGS |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERCK KGAA |
MERIT MEDICAL SYSTEMS INC |
MOLINA HEALTHCARE INC |
NOVARTIS AG |
NOVO NORDISK A/S |
ORION OYJ CLASS B |
PFIZER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
REGENERON PHARMACEUTICALS |
RESMED INC |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
SANOFI SA |
THE CIGNA GROUP |
THERMO FISHER SCIENTIFIC INC |
UCB SA |
UNITED THERAPEUTICS CORP |
UNITEDHEALTH GROUP INC |
VERTEX PHARMACEUTICALS INC |
ZIMMER BIOMET HOLDINGS INC |